Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases
P. W. Yu,
No information about this author
Bin Liu,
No information about this author
Cheng Dong
No information about this author
et al.
Cells,
Journal Year:
2025,
Volume and Issue:
14(8), P. 619 - 619
Published: April 21, 2025
A
significant
increase
in
life
expectancy
worldwide
has
resulted
a
growing
aging
population,
accompanied
by
rise
aging-related
diseases
that
pose
substantial
societal,
economic,
and
medical
challenges.
This
trend
prompted
extensive
efforts
within
many
scientific
communities
to
develop
enhance
therapies
aimed
at
delaying
processes,
mitigating
functional
decline,
addressing
aging-associated
extend
health
span.
Research
biology
focused
on
unraveling
various
biochemical
genetic
pathways
contributing
changes,
including
genomic
instability,
telomere
shortening,
cellular
senescence.
The
advent
of
induced
pluripotent
stem
cells
(iPSCs),
derived
through
reprogramming
human
somatic
cells,
revolutionized
disease
modeling
understanding
humans
the
limitations
conventional
animal
models
primary
cells.
iPSCs
offer
advantages
over
other
such
as
embryonic
they
can
be
obtained
without
need
for
embryo
destruction
are
not
restricted
availability
healthy
donors
or
patients.
These
attributes
position
iPSC
technology
promising
avenue
deciphering
mechanisms
underlie
associated
diseases,
well
studying
drug
effects.
Moreover,
exhibit
remarkable
versatility
differentiating
into
diverse
cell
types,
making
them
tool
personalized
regenerative
replacing
aged
damaged
with
healthy,
equivalents.
review
explores
breadth
research
iPSC-based
their
potential
applications
spectrum
conditions.
Language: Английский
Modern cell culture technologies: Revolutionizing neuroregeneration in neuropsychiatry
Archives of Biological Psychiatry,
Journal Year:
2024,
Volume and Issue:
2, P. 14 - 24
Published: July 6, 2024
This
review
highlights
the
latest
developments
in
current
cell
culture
methods,
including
three-dimensional
culture,
organoids,
coculture
systems,
microfluidics,
and
nanofiber
scaffolds
to
support
neuroregeneration
major
neuropsychiatric
illnesses.
Due
enhanced
vitro
modeling
of
human
brain
structure
function,
these
state-of-the-art
methods
allow
for
investigations
disease
processes
drug
screening,
pathophysiological
research
on
has
increased.
We
examine
recent
relationship
between
technologies
conditions
such
as
stroke,
Alzheimer’s,
traumatic
injury,
spinal
cord
injury.
The
advancements
present
encouraging
prospects
augmenting
could
facilitate
stem
cell-based
therapies
ailments
that
were
previously
untreatable.
Language: Английский
Advances in Mesenchymal Stem Cell Therapy and Natural Antioxidants for Hepatic Fibrosis: A Comprehensive Review
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
2, P. 100016 - 100016
Published: March 1, 2024
Liver
damage
resulting
from
the
administration
of
various
allopathic
drugs
and
their
associated
toxicity
has
become
a
major
health
problem,
leading
to
hepatic
fibrosis,
cirrhosis,
metabolic
disorders.
This
epidemic
condition
liver
disease
represents
global
cause
death
morbidity.
Although
orthotopic
transplantation
remains
vital
treatment
option
for
fibrotic
conditions,
its
efficacy
is
limited
by
organ
scarcity
risk
immunological
rejection.
Consequently,
alternative
therapeutic
approaches
are
urgently
needed.
Cell-based
therapy
utilizing
mesenchymal
stem
cells
(MSCs)
garnered
considerable
interest
as
promising
modality.
MSCs
exhibit
immunomodulatory
properties
can
differentiate
into
hepatocytes,
thus
facilitating
regeneration
damaged
hepatocytes
increasing
residual
hepatocyte
proliferation
while
inhibiting
activation
or
apoptosis
stellate
cells.
However,
despite
potential
benefits,
transplanted
often
low
survival
rates
due
inadequate
oxidative
inflammatory
stress
resistance.
Plants
harbor
diverse
array
bioactive
compounds
known
possess
hepatoprotective
antioxidant
properties.
Nanomaterials
play
crucial
role
in
regenerative
medicine
providing
targeted
delivery
agents
scaffolds
tissue
engineering.
In
treating
liver,
nanomaterials
help
mitigate
fibrosis
progression
promote
through
controlled
release
anti-fibrotic
growth
factors.
review
highlights
synergistic
cell-based
therapy,
natural
antioxidants,
differentiation
factors,
nanotechnology
combating
advancing
medicine.
These
combined
offer
avenues
effectively
conditions
promoting
regeneration.
Language: Английский
Progress of induced pluripotent stem cell (iPSC)-derived renal organoids in clinical application
Kidney Diseases,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 10
Published: Nov. 11, 2024
Background:
Kidney
disease
has
become
a
growing
public
health
problem
worldwide,
and
there
is
an
urgent
need
to
develop
reliable
models
for
investigating
novel
effective
treatment
strategies.
In
recent
years,
kidney
organoids,
as
different
from
traditional
two-dimensional
cells
model
animals,
have
attracted
more
attention.
Current
advances
allowed
the
generation
of
organoids
directed
differentiation
induced
pluripotent
stem
(iPSCs),
which
possess
similar
characteristics
embryonic
cells,
but
bypass
ethical
constraints
wide
range
sources.
Summary:
Herein,
methods
generating
renal
iPSCs,
applications
iPSC-derived
in
modeling,
drug
effectiveness
detection,
regenerative
medicine
well
challenges
were
reviewed.
Key
Messages:
can
be
used
diseases
are
great
studying
injury
toxicity.
Many
efforts
needed
finally
apply
into
clinical
application.
Language: Английский
Liver organoids: From 3D printing to biomedical applications
Ying Shi,
No information about this author
Xin Han,
No information about this author
Zheng Zhang
No information about this author
et al.
BMEMat,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 8, 2024
Abstract
The
liver
is
an
immune
organ,
especially
tolerance
organ.
critical
shortage
of
donor
organs
and
disease
models
for
the
treatment
end‐stage
failure
underscores
urgent
need
generation
organoids
from
human
induced
pluripotent
stem
cells
(iPSCs).
Notably,
significant
advancements
have
been
made
in
study
over
past
decade.
construction
has
transitioned
single
cell
type
to
multicellular
models,
two‐dimensional
three‐dimensional
cultures.
Here
we
provide
progress
surrounding
different
culture
techniques
3D
printing
organ‐on‐chip,
as
well
focuses
on
present
future
applications
organoids,
then
challenges
perspectives
ahead
further
advancement.
Language: Английский